1. Home
  2. EVTV vs MBIO Comparison

EVTV vs MBIO Comparison

Compare EVTV & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envirotech Vehicles Inc.

EVTV

Envirotech Vehicles Inc.

HOLD

Current Price

$2.41

Market Cap

21.6M

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.61

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTV
MBIO
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
5.3M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
EVTV
MBIO
Price
$2.41
$0.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
412.8K
34.2K
Earning Date
04-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.99
EPS
N/A
N/A
Revenue
$5,939,008.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
217.58
N/A
52 Week Low
$0.15
$0.53
52 Week High
$5.07
$7.00

Technical Indicators

Market Signals
Indicator
EVTV
MBIO
Relative Strength Index (RSI) 68.37 33.55
Support Level $1.61 $0.53
Resistance Level $2.66 $0.80
Average True Range (ATR) 0.19 0.04
MACD 0.06 -0.01
Stochastic Oscillator 72.68 18.27

Price Performance

Historical Comparison
EVTV
MBIO

About EVTV Envirotech Vehicles Inc.

Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: